Professional Documents
Culture Documents
Malaria Life
Cycle
Life Cycle
Sporogony
Oocyst
Sporozoites
Mosquito Salivary
Gland
Zygote
Exoerythrocytic
(hepatic) cycle
Gametocytes
Erythrocytic
Cycle
Schizogony
Hypnozoites
(for P. vivax
and P. ovale)
Sporozoires injected
into human host during
blood meal
Parasites
mature in
mosquito
midgut and
migrate to
salivary
glands
MOSQUITO
Parasite undergoes
sexual reproduction in
the mosquito
HUMAN
Some merozoites
differentiate into male or
female gametocyctes
Infective Period
Mosquito bites
uninfected
person
Mosquito bites
gametocytemic
person
Mosquito Vector
Parasites visible
Prepatent Period
Human Host
Symptom onset
Recovery
Incubation Period
Clinical Illness
Clinical presentation
Early symptoms
Headache
Malaise
Fatigue
Nausea
Muscular pains
Slight diarrhea
Slight fever, usually not intermittent
Clinical presentation
Acute febrile illness, may have periodic febrile
paroxysms every 48 72 hours with
Afebrile asymptomatic intervals
Tendency to recrudesce or relapse over months to
years
Anemia, thrombocytopenia, jaundice,
hepatosplenomegaly, respiratory distress syndrome,
renal dysfunction, hypoglycemia, mental status
changes, tropical splenomegaly syndrome
Malarial Paroxysm
Can get prodrome 2-3 days before
Malaise, fever,fatigue, muscle pains, nausea, anorexia
Can mistake for influenza or gastrointestinal infection
Slight fever may worsen just prior to paroxysm
Paroxysm
Cold stage - rigors
Hot stage Max temp can reach 40-41o C, splenomegaly
easily palpable
Sweating stage
Lasts 8-12 hours, start between midnight and midday
Malarial Paroxysm
Periodicity
Days 1 and 3 for P.v., P.o., (and P.f.) - tertian
Usually persistent fever or daily paroxyms for
P.f.
Days 1 and 4 for P.m. - quartian
Differential diagnosis
At the onset of the disease it may be very difficult to
differentiate malaria from viral fevers.
Jaundice and fever is also seen in viral hepatitis and
other forms of hepatitis, cholecystitis and hepatic
abscess.
Dengue, Leptospirosis and hemolytic anemia have
the common triad of pallor, icterus and
splenomegaly.
P. Falciparum-cerebral malaria:A
symmetric encephalopathy
Whenever you see a patient who complains of
headache, vomiting, diplopia, and is disoriented,
confused or behaving abnormally then always
think MALARIA. The relatives may say that he is
always sleepy and had a few convulsions.
On examination, varying levels of consciousness
may be noted with divergent or convergent eyes,
release of primitive reflexes, hyper/hyporeflexia,
hyper/hypotonia, extensor/flexor plantars and
absent abdominals-cremasterics.
Signs of meningeal irritation may also be elicited.
Cerebral Malaria-D/D
Always rule out other causes of altered
sensorium like encephalitis, menigitis and
cerebral bleeds and infarcts.
Check for metabolic parameters and renal and
hepatic failure as other diagnosis or as
contributing to reduced alertness or
convulsions
Tropical splenomegaly
Kala-azar
Portal hypertension hepatic, extrahepatic
Myeloproliferative diseases
Lymphomas
CLL
Diagnosis - malaria
A high index of suspicion is required and a
history of visit to a malarious tract should always
be sought by direct questioning of the patient or
accompanying persons.A history of recent blood
transfusion may point to an iatrogenic mode of
spread of malaria.
Thick and Thin smears should always be examined
and indirect evidence of malaria by demonstrating
hemolytic jaundice should be performed.
Other tests
Generally the complete blood counts and platelets
counts are of little benefit in the diagnosis but aid
in assessing the severity and complications of the
ongoing infection.
PfHRP2 dipstick or card test: monoclonal ab
captures the parasite antigens. Only for falciparum
malaria.
LDH dipstick or card test
CHQ, Amiodaquine
Quinine, Quinidine
Mefloquine, Halofantrine
Lumefantrine
Clindamycin
Azithromycin
Proguanil
Dapsone
Primaquine
Intravenous anti-malarial
therapy- Indications
Presence of vomiting
Inability to start oral therapy may also be due
to altered mental alertness and seizures.
Patients who are intubated and on
ventillators.
Those who are critically ill.
Intra-venous therapy
Chloroquine: intravenous 10 mg/kg max
600mg over 6-8 hrs followed by 15mg/kg
max 900mg over next 24 hrs as slow
infusion.
Quinine : intravenous 20mg/kg over 4 hrs;
then 10mg/kg(max 600mg)three times a
day.
Intra-venous therapy-severe
f.malaria
Artesunate 2.4mg/kg stat; followed by 2.4mg/kg at
12 hrs, 24hrs and then daily. OR
Artemether 3.2mg/kg stat im; then 1.6mg/kg od im.
PLUS
Add quinine 20mg salt/kg over 4 hrs; followed by
10mg/kg over 2-8 hrs slow infusion thrice a day.
PLUS
Doxy 100mg bd / tetra 250mg (4mg/kg) qds
nd
DISEASES SPREAD BY
MOSQUITOS
MALARIA
DENGUE FEVER
YELLOW FEVER
VIRAL ENCEPHALITIS
VIRAL HEMORRHAGIC FEVERS
Malaria
Malaria (contd)
chemoprophylaxis
Chloroquine 5mg base/kg (max 300 mg) once a
week. Begin 1-2 weeks before travel, during stay
and continue till 4 weeks after returning from
malarious area.
Mefloquine 5mg salt/kg (max 250 mg) once a
week. Regime same as above.
Atovoquone/proguanil (250/100mg) 1 tab for travel
to resistant malarious area beginning 1-2 days
before travel and taken daily during stay and ctd till
1 week after return from malarious area.
Congenital malaria
Transplacental infection
Can be all 4 species
Commonly P.v. and P.f. in endemic areas
P.m. infections in nonendemic areas due to long persistence of species